טוען...
FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE
<p>Data on the updated approach to the choice of two-component antihypertensive combinations for different clinical situations are presented. Advantages and indications for combination of an angiotensin converting enzyme (ACE) inhibitor and dihydropyridine calcium antagonist are considered. Da...
שמור ב:
Main Authors: | , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Stolichnaya Izdatelskaya Kompaniya
2015-09-01
|
סדרה: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
נושאים: | |
גישה מקוונת: | http://www.rpcardio.ru/jour/article/view/284 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|